SALAMINO, FRANCA
 Distribuzione geografica
Continente #
EU - Europa 14.296
Totale 14.296
Nazione #
IT - Italia 14.296
Totale 14.296
Città #
Genova 11.565
Rapallo 1.344
Genoa 1.095
Vado Ligure 281
Bordighera 11
Totale 14.296
Nome #
Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients 160
Role of the calpain-calpastatin system in the density-dependent growth arrest 152
Modulation of the calpain autoproteolysis by calpastatin and phospholipids 151
Calpain digestion and HSP90-based chaperone protection modulate the level of plasma membrane F508del-CFTR. 150
Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients 150
A vincristine-resistant murine erythroleukemia cell line secretes a differentiation enhancing factor. 149
The calpain-calpastatin system in mammalian cells: properties and possible functions 146
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients. 145
Effect of extremely low frequency magnetic fields on calpain activation 144
Changes in rabbit-liver lysosomes and fructose 1,6-bisphosphatase induced by cold and fasting. 141
Physiological Roles of Calpain 1 Associated to Multiprotein NMDA Receptor Complex. 139
Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. 138
Autolysis of human erythrocytes calpain produces two active enzyme forms with different cell localization 135
Interactions of Zn2+ and Mg2+ with rabbit liver fructose 1,6 bisphosphatase. 132
Activation of neutrophil calpain following its translocation to the plasma membrane induced by phorbol ester or fMet-Leu-Phe.. 132
Characterization of the calpain/calpastatin system in human hemopoietic cell lines 132
Characterization of a new p94-like calpain form in human lymphocytes 130
Proteolytic degradation of nitric oxide synthase isoforms by calpain is modulated by the expression levels of HSP90. 129
Glucose 6-phosphate dehydrogenase activity in membranes of erythrocytes from normal individuals and subjects with Mediterranean G6PD deficiency. 129
Differential regulation of the calpain-calpastatin complex by the L-domain of calpastatin 129
Regulation of calpain activity in rat brain with altered Ca2+ homeostasis 128
On the mechanism of inhibition of fructose 1,6-bisphosphatase by fructose 2,6-bisphosphate. 128
Characterization of the defective calpain-endogenous calpain inhibitor system in erythrocytes from Milan hypertensive rats. 126
Binding to erythrocyte membrane is the physiological mechanism for activation of Ca2+-dependent neutral proteinase. 126
The role of calpain in the selective increased phosphorylation of the anion-transport protein in red cell of hypertensive subjects. 125
Two cytosolic, Ca2+-dependent, neutral proteinases from rabbit liver: purification and properties of the proenzymes. 125
Changes in calpastatin localization and expression during calpain activation: a new mechanism for the regulation of intracellular Ca(2+)-dependent proteolysis. 124
Properties and intracellular localization of calpain activator protein 124
Cathepsin M: a lysosomal proteinase with aldolase-inactivating activity 123
Involvement of erythrocyte calpain in glycine- and carnitine-treated isovaleric acidemia. 121
Acyl-CoA-binding protein is a potent m-calpain activator 121
The plasma membrane calcium pump is the preferred calpain substrate within the erythrocyte 119
Inactivation of fructose 1,6-bisphosphatase by a lysosomal proteinase is reversed by cystamine. 119
Binding of Zn2+ to rabbit muscle fructose 1,6-bisphosphatase and its effect on the catalytic properties. 118
Cytosolic calcium dependent proteinase of human erythrocytes: formation of an enzyme-natural inhibitor complex induced by Ca2+ ions. 118
Binding of protein kinase C to neutrophil membranes in the presence of Ca2+ and its activation by a Ca2+-requiring proteinase. 117
Changes during fasting in the activity of a specific lysosomal proteinase, fructose-1,6-bisphosphatase converting enzyme. 117
Inactivation of liver aldolase in fasting rabbits: evidence for the accumulation of two different immunoreactive forms. 117
Characterization of the inactive form of fructose-1,6-bisphosphate aldolase isolated from livers of fasted rabbits. 116
Degradation of CFTR-generated protein clusters by calpain: A physiological or a pathological role? 116
The calpastatin defect in hypertension is possibly due to a specific degradation by calpain. 116
Interaction between Calpain-1 and HSP90: New Insights into the Regulation of Localization and Activity of the Protease. 116
Decreased level of calpain inhibitor activity in kidney from Milan hypertensive rats. 114
“In vivo degradation of Nitric-Oxide Synthase isozymes by Calpain is regulated by HSP90” 114
Phosphorylation and proteolytic modification of specific cytoskeletal proteins in human neutrophils stimulated by phorbol 12-myristate 13-acetate. 113
Role of calpain in the regulation of CFTR (cystic fibrosis transmembrane conductance regulator) turnover 113
Activation of NADPH oxidase and phosphorylation of membrane proteins in human neutrophils: coordinate inhibition by a surface antigen-directed monoclonal antibody. 112
Potentiation of NMDA Receptor-Dependent Cell Responses by Extracellular High Mobility Group Box 1 Protein. 112
Role of calpain-1 in the early phase of experimental ALS 111
Isolation and characterization of calpain activator protein from bovine brain. 108
“Susceptibility of NOS isoforms to calpain digestion is modulated by the expression levels of HSP90” 108
Endogenous inhibitors of lysosomal proteinases 108
Regulation of the Ca2+-dependent neutral proteinases from rabbit liver by an endogenous inhibitor. 106
Changes in intracellular localization of calpastatin during calpain activation 105
Limited proteolysis of liver aldolase and fructose 1,6-bisphosphatase by lysosomal proteinases: effect on complex formation. 105
Mechanism of action of a new component of the ca2+dependent proteolytic system in rat brain:the calpain activator 104
Origin of tryptophan in fructose 1,6-bisphosphatase purified from livers of fed rabbits. 104
In vitro correction of erythrocyte glucose 6-phosphate dehydrogenase (G6PD) deficiency. 104
Biochemical responses in activated human neutrophils mediated by protein kinase C and a Ca2+-requiring proteinase. 103
Evidence for the modification of fructose 1,6-bisphosphatase by two distinct lysosomal proteases. 103
Changes in intracellular calpastatin localization are mediated by reversible phosphorylation 102
Proteolysis of human reticulocyte membrane proteins: evidence for a physiological role of the acid endopeptidases. 102
Localization of two lysosomal proteinases on the external surface of the lysosomal membrane. 102
Binding of monoclonal antibody to cathepsin M located on the external surface of rabbit lysosomes. 100
Role of phospholipids in the activation of the Ca2+-dependent neutral proteinase of human erythrocytes. 100
Identification of two calpastatin forms in rat skeletal muscle and their susceptibility to digestion by homologous calpains. 100
Decay of proteinase and peptidase activities of human and rabbit erythrocytes during cellular aging. 100
Age-dependent degradation of calpastatin in kidney of hypertensive rats 100
Different susceptibility of red cell membrane proteins to calpain degradation. 99
Comparative patterns of 'in vitro' oxidative hemolysis of normal and glucose 6-phosphate dehydrogenase (G6PD)-deficient erythrocytes. 99
Is the Expression of [-G93A(+)] human SOD1 a model to study neurodegenerations? 98
Characterization of three rabbit liver lysosomal proteinases with fructose 1,6-bisphosphatase converting enzyme activity. 97
Changes in activity of fructose-1,6-bisphosphate aldolase in livers of fasted rabbits and accumulation of crossreacting immune material. 97
Evidence for an interaction between fructose 1,6-bisphosphatase and fructose 1,6-bisphosphate aldolase. 96
Identification of proteolytic activities in the cytosolic compartment of mature human erythrocytes. 96
Identification of an endogenous activator of calpain in rat skeletal muscle. 95
Interaction of rabbit liver cathepsin M and fructose 1,6-bisphosphatase converting enzyme with their endogenous inhibitors. 95
Phosphorylation of rat brain calpastatins by protein kinase C. 94
Cytolytic effects of neutrophils: role for a membrane-bound neutral proteinase. 94
Decreased level of calpain inhibitor activity in red blood cells from Milan hypertensive rats. 94
Phosphorylation of proteins in human neutrophils activated with phorbol myristate acetate or with chemotactic factor. 94
In vivo degradation of nitric oxide synthase (NOS) and heat shock protein 90 (HSP90) by calpain is modulated by the formation of a NOS-HSP90 heterocomplex 93
Biotechnological traps for the reduction of inflammation due to cardiopulmonary bypass. 93
Cytosolic calcium dependent neutral proteinase of human erythrocytes: the role of calcium ions on the molecular and catalytic properties of the enzyme. 92
"Association of calpastatin with inactive calpain: a novel mechanism to control the activation of the protease?" 92
Differences and similarities among three acidic endopeptidases associated with human erythrocyte membranes. Molecular and functional studies. 92
Modulation of inhibitory efficiency of rat skeletal muscle calpastatin by phosphorylation. 91
Cytosolic Ca2+-dependent neutral proteinases from rabbit liver: activation of the proenzymes by Ca2+ and substrate. 91
Changes in activity and molecular properties of fructose 1, 6-bisphosphatase during fasting and refeeding. 91
Hormonal effects on structure and catalytic properties of fructose 1,6-bisphosphatase.. 91
Phosphorylation by protein kinase C of a 20-kDa cytoskeletal polypeptide enhances its susceptibility to digestion by calpain. 90
Calpain-mediated activation of NO synthase in human neuroblastoma SK-N-BE cells 89
An endogenous activator of the Ca2+-dependent proteinase of human neutrophils that increases its affinity for Ca2+. 88
Following association to the membrane, human erythrocyte procalpain is converted and released as fully active calpain. 88
Effects of a monoclonal anti-calpain antibody on responses of stimulated human neutrophils. Evidence for a role for proteolytically modified protein kinase C. 87
The reversible activation by Mn2+ ions of the Ca2+-requiring neutral proteinase of human erythrocytes. 87
Characterization of the single peptide generated from the amino-terminus end of alpha- and beta-hemoglobin chains by the Ca2+-dependent neutral proteinase. 86
Participation of protein kinase C in the activation of human neutrophils by phorbol ester 86
Calpain: from structure to biological function 86
Molecular and functional properties of a calpain activator protein specific for miu-calpain 86
Totale 11.173
Categoria #
all - tutte 35.123
article - articoli 31.079
book - libri 0
conference - conferenze 3.483
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 561
Totale 70.246


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.718 0 0 238 255 367 406 566 261 347 669 459 150
2020/2021881 52 92 52 56 65 88 51 78 91 94 84 78
2021/20221.633 42 98 88 202 68 127 144 307 66 173 70 248
2022/20231.597 145 84 16 216 244 316 0 103 297 12 150 14
2023/2024762 40 95 8 77 115 174 17 29 49 18 40 100
2024/2025373 173 192 8 0 0 0 0 0 0 0 0 0
Totale 14.373